SD

Shatakhshi Dube

Active Director Director DIN 10937466
DIN 10937466 First appointment Feb 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Shatakhshi Dube

Data last updated:

Shatakhshi Dube is a Director at Nasira Nutraceuticals Private Limited (since 2025) and Director at Wobomi Ventures Private Limited (since 2025). The companies operate in Pharma and Paper.

DIN 10937466
Primary Designation Director
Industry Pharma
First Appointment 04 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Apr 20252025Active
Wobomi Ventures Private Limited U21003TS2025PTC193679
Director04 Feb 20252025Active

Board colleagues of Shatakhshi Dube

Directorship timeline

Open interactive timeline →
Nasira Nutraceuticals Private Limited
Wobomi Ventures Private Limited
Premium access

Shareholding and investment profile for Shatakhshi Dube

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shatakhshi Dube

Shatakhshi Dube currently holds 2 directorships: Nasira Nutraceuticals Private Limited (Director, since 16 Apr 2025); Wobomi Ventures Private Limited (Director, since 04 Feb 2025).

Shatakhshi Dube was first appointed on 04 Feb 2025 as Director at Wobomi Ventures Private Limited.

The current boards of Shatakhshi Dube's companies include Nasira Hameduddin (Nasira Nutraceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available